Enlivex Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	4.08	3.3	0.81	49.95	11.2	5.67
Short-Term Investments	14.12	20.2	26.51	0.3	72.93	30.03
Cash & Short-Term Investments	18.2	23.5	27.32	50.24	84.13	35.71
Cash Growth	-25.72%	-14.00%	-45.63%	-40.28%	135.61%	197.36%
Other Receivables	0.76	1.42	0.23	0.65	1.2	-
Receivables	0.76	1.42	0.23	0.65	1.2	-
Prepaid Expenses	0.53	0.88	1.11	1.44	1.11	1.24
Restricted Cash	-	-	-	-	-	1.17
Other Current Assets	0.01	0.2	5.11	-	-	-
Total Current Assets	19.5	25.99	33.76	52.33	86.44	38.12
Property, Plant & Equipment	1.08	1.15	2.58	14.9	8.22	2.14
Other Long-Term Assets	0.36	0.54	0.49	0.41	0.49	0.1
Total Assets	20.94	27.69	36.83	67.64	95.15	40.36
Accounts Payable	0.38	0.81	0.83	1.95	0.88	0.46
Accrued Expenses	2.38	2.61	3.66	4.01	3.22	2.54
Current Portion of Leases	0.28	0.24	0.35	0.65	0.62	0.2
Other Current Liabilities	-	0.14	1.23	-	-	1.17
Total Current Liabilities	3.03	3.8	6.06	6.61	4.72	4.37
Long-Term Leases	0.43	0.3	0.69	4.19	5.39	0.5
Total Liabilities	3.46	4.1	6.75	10.8	10.11	4.87
Common Stock	2.76	2.69	2.14	2.12	2.11	1.65
Additional Paid-In Capital	148.25	146.91	138.94	136.65	133.8	70.36
Retained Earnings	-134.63	-127.11	-112.09	-83.03	-51.97	-37.5
Comprehensive Income & Other	1.1	1.1	1.1	1.1	1.1	0.98
Total Common Equity	17.48	23.59	30.08	56.84	85.04	35.49
Shareholders' Equity	17.48	23.59	30.08	56.84	85.04	35.49
Total Liabilities & Equity	20.94	27.69	36.83	67.64	95.15	40.36
Total Debt	0.7	0.53	1.03	4.85	6.01	0.7
Net Cash (Debt)	17.5	22.96	26.29	45.4	78.12	35.01
Net Cash Growth	-26.28%	-12.65%	-42.09%	-41.89%	123.18%	202.11%
Net Cash Per Share	0.74	1.12	1.42	2.47	4.37	2.66
Filing Date Shares Outstanding	24.29	23.65	18.6	18.42	18.37	18.31
Total Common Shares Outstanding	24.29	23.65	18.6	18.42	18.33	14.59
Working Capital	16.47	22.19	27.7	45.72	81.72	33.75
Book Value Per Share	0.72	1.00	1.62	3.09	4.64	2.43
Tangible Book Value	17.48	23.59	30.08	56.84	85.04	35.49
Tangible Book Value Per Share	0.72	1.00	1.62	3.09	4.64	2.43
Machinery	2.72	2.68	2.98	3.38	2.34	1.53
Leasehold Improvements	0.95	0.95	1.43	8.61	1.52	0.71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q